Explain this page
Arphra AIPlain-English read on Tyson Foods, Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +13.87% | +12.51% | +4.98% | +6.80% | +6.54% | +6.18% | +6.16% | +6.15% | +6.26% |
| Operating margin | +9.34% | +8.28% | -0.75% | +2.64% | +2.65% | +1.55% | +1.51% | +1.49% | +1.52% |
| EBITDA margin | +12.08% | +10.73% | +1.92% | +5.58% | +4.74% | +3.98% | +4.03% | +4.18% | +4.15% |
| EBIT margin | +9.50% | +8.47% | -0.61% | +2.95% | +2.24% | +1.49% | +1.53% | +1.52% | +1.53% |
| Pre-tax margin | +8.59% | +7.79% | -1.28% | +2.05% | +1.41% | +0.71% | +0.73% | +0.73% | +0.72% |
| Net margin | +6.48% | +6.08% | -1.23% | +1.50% | +0.87% | +0.38% | +0.37% | +0.38% | +0.39% |
| Cost structure | |||||||||
| Cost of revenue / sales | +86.13% | +87.49% | +95.02% | +93.20% | +93.46% | +91.44% | +92.47% | +94.22% | +93.18% |
| R&D intensity | +0.24% | +0.20% | +0.22% | +0.20% | +0.23% | +0.22% | +0.21% | +0.21% | +0.21% |
| SG&A intensity | +4.53% | +4.16% | +4.08% | +4.11% | +3.90% | +4.12% | +4.05% | +4.00% | +4.02% |
| Effective tax rate | +24.28% | +21.69% | — | +24.73% | +34.07% | +29.95% | +29.06% | +29.72% | +29.04% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +17.07% | +16.34% | -3.55% | +4.32% | +2.60% | +1.08% | +1.08% | +1.15% | +1.15% |
| Return on assets (ROA) | +8.39% | +8.79% | -1.79% | +2.16% | +1.29% | +0.56% | +0.53% | +0.57% | +0.58% |
| Return on capital (ROC) | +16.16% | +15.68% | -1.42% | +4.98% | +5.33% | +2.99% | +2.89% | +2.92% | +2.96% |
| Return on invested capital (ROIC) | +11.20% | +11.51% | -1.07% | +2.83% | +1.75% | +0.73% | +0.71% | +0.75% | +0.76% |
| Asset turnover | +129.58% | +144.71% | +145.87% | +143.69% | +148.51% | +147.82% | +141.78% | +149.47% | +147.39% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +6.48% | +6.08% | -1.23% | +1.50% | +0.87% | +0.38% | +0.37% | +0.38% | +0.39% |
| Asset turnover (× revenue / assets) | +129.58% | +144.71% | +145.87% | +143.69% | +148.51% | +147.82% | +141.78% | +149.47% | +147.39% |
| Equity multiplier (× assets / equity) | +203.37% | +185.86% | +198.58% | +200.39% | +201.12% | +194.65% | +205.30% | +201.20% | +199.66% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 1.30 | 1.45 | 1.46 | 1.44 | 1.49 | 1.48 | 1.42 | 1.49 | 1.47 |
| Fixed-asset turnover | 6.00 | 6.13 | 5.49 | 5.65 | 5.91 | — | — | — | — |
| Inventory turnover | 9.25 | 8.45 | 9.43 | 9.56 | 8.96 | — | — | — | — |
| Receivables turnover | 19.60 | 20.68 | 21.36 | 22.16 | 21.57 | — | — | — | — |
| Payables turnover | 18.21 | 18.77 | 19.37 | 20.68 | 19.56 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 18.62 | 17.65 | 17.09 | 16.47 | 16.92 | — | — | — | — |
| Days inventory outstanding (DIO) | 39.47 | 43.18 | 38.70 | 38.17 | 40.75 | — | — | — | — |
| Days payables outstanding (DPO) | 20.04 | 19.44 | 18.84 | 17.65 | 18.66 | — | — | — | — |
| Cash conversion cycle | 38.05 | 41.39 | 36.95 | 36.99 | 39.02 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 1.26 | 0.83 | -2.70 | 3.24 | 4.55 | 10.44 | 11.02 | 10.30 | 10.55 |
| FCF / Net income | 0.86 | 0.25 | 0.29 | 1.82 | 2.48 | 3.97 | 4.06 | 3.94 | 3.85 |
| FCF margin | +5.59% | +1.50% | -0.35% | +2.73% | +2.16% | +1.50% | +1.51% | +1.51% | +1.51% |
| OCF margin | +8.16% | +5.04% | +3.31% | +4.86% | +3.96% | +3.93% | +4.10% | +3.94% | +4.13% |
| CapEx / Revenue | +2.57% | +3.54% | +3.67% | +2.12% | +1.80% | +2.54% | +2.53% | +2.56% | +2.51% |
| CapEx / D&A | 1.00 | 1.57 | 1.45 | 0.81 | 0.72 | — | — | — | — |
| Stock-based comp / Revenue | +0.19% | +0.17% | +0.12% | +0.19% | +0.18% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 8.34 | 8.92 | -1.87 | 2.25 | 1.36 | 4.06 | 4.52 | 5.67 | 6.59 |
| EPS · basic | 8.57 | 9.18 | -1.87 | 2.31 | 1.36 | 4.06 | 4.62 | 5.75 | 6.56 |
| Book value / share | 48.92 | 54.58 | 51.57 | 52.01 | 52.38 | 56.92 | 55.65 | 55.74 | 58.77 |
| Tangible BV / share | 2.15 | 8.39 | 6.44 | 7.92 | 9.01 | 56.92 | 55.65 | 55.74 | 58.77 |
| Sales / share | 128.90 | 146.78 | 149.38 | 149.74 | 156.44 | 163.77 | 161.97 | 167.63 | 172.94 |
| Operating CF / share | 10.52 | 7.40 | 4.95 | 7.28 | 6.19 | 6.44 | 6.63 | 6.60 | 7.14 |
| Free cash flow / share | 7.21 | 2.20 | -0.53 | 4.10 | 3.38 | 2.45 | 2.45 | 2.53 | 2.61 |
| Dividends / share | 1.74 | 1.80 | 1.89 | 1.92 | 2.00 | 2.05 | 2.10 | 2.11 | 2.15 |
| Payout ratio | +20.87% | +20.17% | -103.40% | +85.50% | +147.05% | +331.76% | +348.29% | +328.84% | +318.53% |
| Retention ratio | +79.13% | +79.83% | +203.40% | +14.50% | -47.05% | -231.76% | -248.29% | -228.84% | -218.53% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +13.25% | -0.75% | +0.81% | +2.12% | +3.87% | +0.58% | +2.26% | +4.39% | +3.24% |
| Gross profit · YoY | — | +2.18% | -60.54% | +37.86% | -1.79% | -1.93% | +0.23% | +2.10% | +6.37% | -6.53% |
| Profit | ||||||||||
| Operating income · YoY | — | +0.32% | -108.96% | +456.71% | +2.27% | -39.01% | -2.06% | +0.41% | +6.98% | -17.71% |
| EBITDA · YoY | — | +0.58% | -82.23% | +192.62% | -13.25% | -12.63% | +1.78% | +5.92% | +3.64% | -9.68% |
| Net income · YoY | — | +6.27% | -120.01% | +223.46% | -40.75% | -55.05% | -0.78% | +5.17% | +6.82% | -27.31% |
| Operating | ||||||||||
| EBIT · YoY | — | +1.01% | -107.16% | +587.00% | -22.57% | -30.87% | +3.20% | +1.94% | +4.67% | -17.85% |
| R&D · YoY | — | -5.26% | +5.56% | -7.02% | +18.87% | -1.99% | -2.69% | +3.78% | +4.02% | +1.63% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +6.95% | -120.96% | +220.32% | -39.56% | +198.64% | +11.30% | +25.53% | +16.08% | -2.91% |
| EPS · basic · YoY | — | +7.12% | -120.37% | +223.53% | -41.13% | +198.20% | +14.03% | +24.29% | +14.13% | -3.29% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $9.35B | $8.32B | $9.51B | $9.79B | $8.83B | $9.7B | $10.2B | $10.28B | $10.65B |
| Net debt | $6.84B | $7.29B | $8.93B | $8.07B | $7.6B | $8.45B | $8.95B | $9B | $9.31B |
| Net debt / EBITDA | 1.20 | 1.28 | 8.79 | 2.71 | 2.95 | 3.75 | 3.90 | 3.70 | 3.70 |
| Debt / equity | 0.52 | 0.42 | 0.52 | 0.53 | 0.48 | 0.49 | 0.52 | 0.53 | 0.52 |
| Debt / assets | +25.75% | +22.60% | +26.22% | +26.38% | +24.09% | +25.35% | +25.43% | +26.42% | +25.86% |
| Equity / assets | +49.17% | +53.80% | +50.36% | +49.90% | +49.72% | +51.38% | +48.71% | +49.70% | +50.09% |
| Coverage | |||||||||
| EBITDA / interest expense | 13.28 | 15.66 | 2.86 | 6.18 | 5.74 | 5.03 | 4.98 | 5.13 | 5.30 |
| Operating income / interest | 10.27 | 12.08 | -1.11 | 2.93 | 3.21 | 1.96 | 1.87 | 1.83 | 1.95 |
| Interest expense | $428M | $365M | $355M | $481M | $449M | $447.9M | $460.61M | $473.3M | $474.71M |
| Liquidity | |||||||||
| Current ratio | 1.55 | 1.81 | 1.34 | 2.04 | 1.55 | — | — | — | — |
| Quick ratio | 0.78 | 0.68 | 0.47 | 0.86 | 0.59 | — | — | — | — |
| Cash ratio | 0.40 | 0.19 | 0.09 | 0.36 | 0.19 | — | — | — | — |
| Working capital | $3.5B | $4.32B | $2.22B | $4.96B | $3.53B | — | — | — | — |
| Working capital / revenue | +7.43% | +8.10% | +4.20% | +9.31% | +6.48% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).